Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
BMJ Case Reports|December 18, 2013
The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers?Mari Frances Kilner, Serena Merante, Alexandr Svec
Immunological Reviews|April 5, 2013
The role of miRNAs in mast cells and other innate immune cellsSara Montagner, Ester M Orlandi, Serena Merante, et al.
Haematologica|July 6, 2005
Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuationSerena Merante, Ester Orlandi, Paolo Bernasconi, et al.
Haematologica|July 20, 2004
TP53 codon 72 polymorphism in patients with chronic myeloid leukemiaGaetano Bergamaschi, Serena Merante, Ester Orlandi, et al.
Haematologica|April 13, 2004
Hypereosinophilic syndrome and cyclic oscillations in blood cell counts. A clonal disorder of hematopoiesis originating in a pluripotent stem cellLuca Malcovati, Roberta La Starza, Serena Merante, et al.
Photodermatology, Photoimmunology & Photomedicine|June 30, 2016
Narrow-band UVB phototherapy and psoralen-ultraviolet A photochemotherapy in the treatment of cutaneous mastocytosis: a study in 20 patientsValeria Brazzelli, Sara Grassi, Serena Merante, et al.
Hematology (Amsterdam, Netherlands)|June 21, 2016
'Real-life' study of imatinib therapy in chronic phase-chronic myeloid leukemia: A novel retrospective observational longitudinal analysisSerena Merante, Virginia Ferretti, Chiara Elena, et al.
European Journal of Haematology|February 18, 2015
Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosisCristina Leoni, Sara Montagner, Lorenzo Deho', et al.
Digestive Diseases and Sciences|March 12, 2015
The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn's Disease: A Cross-Sectional StudyRachele Ciccocioppo, Venerina Imbesi, Elena Betti, et al.
Haematologica|January 16, 2009
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-upFrancesca Palandri, Fausto Castagnetti, Giuliana Alimena, et al.
Pageof 2